Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Amicus Therapeutics Current Ratio 2007-2019 | FOLD

Amicus Therapeutics current ratio from 2007 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Amicus Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.58B $0.09B 6.20
2019-06-30 $0.64B $0.09B 7.09
2019-03-31 $0.48B $0.07B 7.33
2018-12-31 $0.55B $0.09B 6.40
2018-09-30 $0.60B $0.07B 9.12
2018-06-30 $0.58B $0.05B 10.88
2018-03-31 $0.59B $0.14B 4.21
2017-12-31 $0.39B $0.07B 5.60
2017-09-30 $0.43B $0.07B 6.32
2017-06-30 $0.24B $0.10B 2.39
2017-03-31 $0.30B $0.11B 2.70
2016-12-31 $0.34B $0.11B 3.07
2016-09-30 $0.22B $0.09B 2.59
2016-06-30 $0.22B $0.08B 2.71
2016-03-31 $0.17B $0.06B 2.62
2015-12-31 $0.22B $0.07B 2.94
2015-09-30 $0.24B $0.04B 6.69
2015-06-30 $0.37B $0.02B 21.60
2015-03-31 $0.15B $0.02B 7.20
2014-12-31 $0.16B $0.02B 7.66
2014-09-30 $0.09B $0.01B 6.31
2014-06-30 $0.08B $0.01B 7.11
2014-03-31 $0.07B $0.01B 7.84
2013-12-31 $0.09B $0.01B 8.44
2013-09-30 $0.06B $0.01B 7.48
2013-06-30 $0.08B $0.01B 7.74
2013-03-31 $0.09B $0.01B 10.98
2012-12-31 $0.11B $0.01B 11.32
2012-09-30 $0.11B $0.01B 11.33
2012-06-30 $0.11B $0.02B 5.93
2012-03-31 $0.12B $0.02B 6.49
2011-12-31 $0.07B $0.02B 3.46
2011-09-30 $0.08B $0.02B 4.10
2011-06-30 $0.09B $0.02B 5.22
2011-03-31 $0.10B $0.02B 6.01
2010-12-31 $0.11B $0.02B 6.76
2010-09-30 $0.06B $0.01B 7.42
2010-06-30 $0.07B $0.01B 9.96
2010-03-31 $0.08B $0.01B 9.50
2009-12-31 $0.08B $0.01B 7.19
2009-09-30 $0.09B $0.02B 5.48
2009-06-30 $0.10B $0.02B 6.77
2009-03-31 $0.11B $0.01B 8.84
2008-12-31 $0.12B $0.01B 9.24
2008-09-30 $0.14B $0.02B 9.26
2008-06-30 $0.15B $0.02B 9.58
2008-03-31 $0.16B $0.02B 10.51
2007-12-31 $0.16B $0.02B 10.32
2007-09-30 $0.12B $0.01B 12.61
2007-06-30 $0.13B $0.01B 18.26
2007-03-31 $0.00B 0.00
2006-09-30 $0.00B 0.00
2006-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.500B $0.091B
AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $124.084B 14.19
CSL (CSLLY) Australia $95.484B 0.00
Gilead Sciences (GILD) United States $88.687B 11.42
Vertex Pharmaceuticals (VRTX) United States $59.632B 54.12
Biogen (BIIB) United States $56.416B 9.63
Regeneron Pharmaceuticals (REGN) United States $48.666B 20.61
Illumina (ILMN) United States $39.683B 41.03
Alexion Pharmaceuticals (ALXN) United States $21.285B 9.90
Seattle Genetics (SGEN) United States $19.359B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.724B 0.00
Incyte (INCY) United States $16.761B 35.96
BioMarin Pharmaceutical (BMRN) United States $16.346B 0.00
Genmab (GNMSF) Denmark $14.867B 47.82
Alnylam Pharmaceuticals (ALNY) United States $13.430B 0.00
Galapagos (GLPG) Belgium $13.052B 33.63
Exact Sciences (EXAS) United States $12.804B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.564B 54.03
BeiGene (BGNE) Cayman Islands $9.685B 0.00
Sarepta Therapeutics (SRPT) United States $8.482B 0.00
Moderna (MRNA) United States $7.996B 0.00
QIAGEN (QGEN) Netherlands $7.888B 24.29
Bio-Techne Corp (TECH) United States $7.580B 51.87
BioNTech SE (BNTX) Germany $7.566B 0.00
Guardant Health (GH) United States $7.117B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.346B 16.13
ACADIA Pharmaceuticals (ACAD) United States $6.264B 0.00
Amarin (AMRN) Ireland $6.251B 0.00
Ascendis Pharma (ASND) Denmark $6.218B 0.00
Reata Pharmaceuticals (RETA) United States $5.939B 0.00
Exelixis (EXEL) United States $5.895B 19.02
ARGENX SE-ADR (ARGX) Netherlands $5.850B 0.00
Acceleron Pharma (XLRN) United States $4.681B 0.00
China Biologic Products (CBPO) China $4.566B 25.72
Repligen (RGEN) United States $4.423B 80.91
Bluebird Bio (BLUE) United States $4.044B 0.00
Adaptive Biotechnologies (ADPT) United States $3.730B 0.00
MorphoSys AG (MOR) Germany $3.611B 0.00
Mirati Therapeutics (MRTX) United States $3.338B 0.00
Zai Lab (ZLAB) China $3.214B 0.00
Blueprint Medicines (BPMC) United States $3.202B 0.00
Immunomedics (IMMU) United States $3.179B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.172B 0.00
Alkermes (ALKS) Ireland $3.145B 249.13
Genmab (GMAB) Denmark $3.130B 12.28
Emergent Biosolutions (EBS) United States $3.093B 21.63
NeoGenomics (NEO) United States $3.076B 163.67
Momenta Pharmaceuticals (MNTA) United States $3.050B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.036B 51.43
MyoKardia (MYOK) United States $2.974B 0.00
Halozyme Therapeutics (HALO) United States $2.875B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.772B 0.00
Arena Pharmaceuticals (ARNA) United States $2.395B 5.57
UniQure (QURE) Netherlands $2.378B 0.00
Insmed (INSM) United States $2.353B 0.00
Fate Therapeutics (FATE) United States $2.296B 0.00
RA PHARMCTL INC (RARX) United States $2.200B 0.00
Denali Therapeutics (DNLI) United States $2.120B 0.00
Principia Biopharma (PRNB) United States $2.089B 0.00
Epizyme (EPZM) United States $1.957B 0.00
Alector (ALEC) United States $1.888B 0.00
REGENXBIO (RGNX) United States $1.750B 0.00
Ligand Pharmaceuticals (LGND) United States $1.746B 50.99
Arvinas (ARVN) United States $1.620B 0.00
Akcea Therapeutics (AKCA) United States $1.606B 37.17
Zymeworks (ZYME) Canada $1.592B 0.00
Coherus BioSciences (CHRS) United States $1.494B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.396B 0.00
Zealand Pharma (ZEAL) Denmark $1.367B 0.00
Myriad Genetics (MYGN) United States $1.341B 23.67
Nabriva Therapeutics AG (NBRV) Ireland $1.333B 0.00
Intra-Cellular Therapies (ITCI) United States $1.276B 0.00
Editas Medicine (EDIT) United States $1.153B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.149B 0.00
Twist Bioscience (TWST) United States $1.124B 0.00
Revance Therapeutics (RVNC) United States $1.117B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.050B 0.00
Athenex (ATNX) United States $1.009B 0.00
PHARMA MAR SA (PHMMF) Spain $0.941B 0.00
Cytokineticsorporated (CYTK) United States $0.870B 0.00
DBV Technologies S.A (DBVT) France $0.860B 0.00
Pharming Group (PHGUF) Netherlands $0.857B 0.00
Adverum Biotechnologies (ADVM) United States $0.849B 0.00
Mesoblast (MESO) Australia $0.827B 0.00
Sangamo Therapeutics (SGMO) United States $0.788B 0.00
Heska (HSKA) United States $0.781B 0.00
Codexis (CDXS) United States $0.758B 0.00
Vericel (VCEL) United States $0.746B 111.27
Intrexon (PGEN) United States $0.706B 0.00
ANI Pharmaceuticals (ANIP) United States $0.698B 11.90
Cellectis S.A (CLLS) France $0.694B 0.00
Arcus Biosciences (RCUS) United States $0.682B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
Cara Therapeutics (CARA) United States $0.640B 0.00
Retrophin (RTRX) United States $0.621B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.612B 5.41
Anika Therapeutics (ANIK) United States $0.608B 20.78
UROGEN PHARMA (URGN) United States $0.599B 0.00
Cel-Sci (CVM) United States $0.596B 0.00
Intellia Therapeutics (NTLA) United States $0.592B 0.00
GENFIT S.A (GNFT) France $0.591B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.579B 0.00
Kadmon Holdings (KDMN) United States $0.558B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.523B 0.00
Bellus Health (BLU) Canada $0.513B 0.00
AC Immune SA (ACIU) Switzerland $0.493B 11.39
Prothena (PRTA) Ireland $0.485B 0.00
NantKwest (NK) United States $0.481B 0.00
Compugen (CGEN) Israel $0.464B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
BioDelivery Sciences (BDSI) United States $0.457B 0.00
Puma Biotechnology (PBYI) United States $0.441B 0.00
Clovis Oncology (CLVS) United States $0.438B 0.00
Cue Biopharma (CUE) United States $0.434B 0.00
Mersana Therapeutics (MRSN) United States $0.430B 0.00
AnaptysBio (ANAB) United States $0.423B 0.00
Agenus (AGEN) United States $0.408B 0.00
Precision BioSciences (DTIL) United States $0.407B 0.00
Kindred Biosciences (KIN) United States $0.406B 0.00
Merus (MRUS) Netherlands $0.405B 0.00
Pfenex (PFNX) United States $0.401B 0.00
PDL BioPharma (PDLI) United States $0.384B 9.60
Inovio Pharmaceuticals (INO) United States $0.379B 0.00
Sorrento Therapeutics (SRNE) United States $0.378B 0.00
Avid Bioservices (CDMO) United States $0.377B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.375B 0.00
Dynavax Technologies (DVAX) United States $0.370B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.366B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.358B 0.00
Cellular Biomedicine (CBMG) United States $0.327B 0.00
CytomX Therapeutics (CTMX) United States $0.322B 0.00
Gritstone Oncology (GRTS) United States $0.319B 0.00
Stemline Therapeutics (STML) United States $0.316B 0.00
Albireo Pharma (ALBO) United States $0.308B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.303B 2.10
WAVE Life Sciences (WVE) Singapore $0.285B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.279B 0.00
MannKind (MNKD) United States $0.279B 0.00
Aduro Biotech (ADRO) United States $0.279B 0.00
Starpharma Holdings (SPHRY) Australia $0.276B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.270B 0.00
Kamada (KMDA) Israel $0.268B 11.13
Syros Pharmaceuticals (SYRS) United States $0.267B 0.00
OSMOTICA PHARM (OSMT) United States $0.265B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.262B 0.00
Novavax (NVAX) United States $0.255B 0.00
Biofrontera AG (BFRA) Germany $0.246B 0.00
Seres Therapeutics (MCRB) United States $0.235B 0.00
Sutro Biopharma (STRO) United States $0.235B 0.00
Protagonist Therapeutics (PTGX) United States $0.233B 0.00
IVERIC Bio (ISEE) United States $0.230B 0.00
Geron (GERN) United States $0.230B 0.00
Kala Pharmaceuticals (KALA) United States $0.225B 0.00
VBI Vaccines (VBIV) United States $0.223B 0.00
POXEL SA FRANCE (PXXLF) France $0.220B 0.00
XOMA (XOMA) United States $0.219B 0.00
Prometic Life Sciences (LMNL) Canada $0.212B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.210B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.210B 0.00
Alcobra (ARCT) United States $0.208B 0.00
TELA Bio (TELA) United States $0.202B 0.00
Abeona Therapeutics (ABEO) United States $0.199B 0.00
ADMA Biologics Inc (ADMA) United States $0.198B 0.00
ChromaDex (CDXC) United States $0.195B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.193B 9.92
Athersys (ATHX) United States $0.193B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.192B 0.00
Arbutus Biopharma (ABUS) Canada $0.186B 0.00
Theratechnologies (THTX) Canada $0.186B 0.00
Cerecor (CERC) United States $0.180B 0.00
Spero Therapeutics (SPRO) United States $0.179B 0.00
Five Prime Therapeutics (FPRX) United States $0.177B 0.00
Affimed (AFMD) Germany $0.177B 0.00
VTv Therapeutics (VTVT) United States $0.173B 0.00
Exicure (XCUR) United States $0.173B 0.00
VolitionRX (VNRX) Singapore $0.172B 0.00
Fortress Biotech (FBIO) United States $0.169B 0.00
Windtree Therapeutics (WINT) United States $0.164B 0.00
Selecta Biosciences (SELB) United States $0.151B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.147B 0.00
Verastem (VSTM) United States $0.146B 0.00
Dyadic (DYAI) United States $0.145B 0.00
CorMedix Inc (CRMD) United States $0.144B 0.00
Strongbridge Biopharma (SBBP) United States $0.144B 0.00
Aptinyx (APTX) United States $0.142B 0.00
Northwest Biotherapeutics (NWBO) United States $0.141B 0.00
Liquidia Technologies (LQDA) United States $0.137B 0.00
Antibe Therapeutics (ATBPF) Canada $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Celyad SA (CYAD) Belgium $0.133B 0.00
ARAVIVE, INC (ARAV) United States $0.131B 0.00
Arsanis (XFOR) United States $0.130B 0.00
Palatin Technologies (PTN) United States $0.128B 3.48
PHASEBIO PHARMA (PHAS) United States $0.125B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.120B 0.00
OvaScience (MLND) United States $0.116B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.115B 0.00
Enzo Biochem (ENZ) United States $0.114B 0.00
Happiness Biotech Group (HAPP) China $0.114B 0.00
Clearside Biomedical (CLSD) United States $0.114B 0.00
Menlo Therapeutics (MNLO) United States $0.107B 0.00
Prima BioMed (IMMP) Australia $0.106B 0.00
Vaccinex (VCNX) United States $0.099B 0.00
AIT Therapeutics (XAIR) United States $0.095B 0.00
Proteostasis Therapeutics (PTI) United States $0.093B 0.00
Checkpoint Therapeutics (CKPT) United States $0.091B 0.00
Applied Genetic Technologies (AGTC) United States $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
SESEN BIO, INC (SESN) United States $0.082B 0.00
Emmaus Life Sciences (EMMA) United States $0.080B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.079B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Catalyst Biosciences (CBIO) United States $0.075B 0.00
Pluristem Therapeutics (PSTI) Israel $0.072B 0.00
Orgenesis (ORGS) United States $0.068B 4.40
ANIXA BIOSCIENCES INC (ANIX) United States $0.067B 0.00
Acorda Therapeutics (ACOR) United States $0.066B 0.00
Trevena (TRVN) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.065B 0.00
Soligenix (SNGX) United States $0.062B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.061B 0.00
DiaMedica Therapeutics (DMAC) United States $0.060B 0.00
China Health Industries Holdings (CHHE) China $0.056B 16.98
NewLink Genetics (NLNK) United States $0.055B 0.00
Advaxis (ADXS) United States $0.053B 0.00
Protalix BioTherapeutics (PLX) Israel $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Curis (CRIS) United States $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
AquaBounty Technologies (AQB) United States $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.044B 0.00
TOCAGEN INC (TOCA) United States $0.042B 0.00
Organovo Holdings (ONVO) United States $0.040B 0.00
AmpliPhi Biosciences (ARMP) United States $0.038B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Stellar Biotechnologies (EDSA) Canada $0.030B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Pulmatrix (PULM) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Celsion (CLSN) United States $0.026B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Oncobiologics (OTLK) United States $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
IBio (IBIO) United States $0.024B 0.00
VIVUS (VVUS) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Unum Therapeutics (UMRX) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.014B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Cesca Therapeutics (THMO) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
BioPharmX (BPMX) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00